Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canal and iPACK Blocks for Total Knee Arthroplasty
NCT07097493Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2027
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Wake Forest University Health Sciences. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07097493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07097493.